FindTrial
Sign In

Impact of intraoperative autogeneic and allogeneic transfusion on early postoperative coagulation in patients undergoing neurosurgery

Impact of intraoperative autogeneic and allogeneic transfusion on early postoperative coagulation in patients undergoing neurosurgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047055
Enrollment
Unknown
Registered
2021-06-07
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurosurgery

Interventions

Experimental group1:autogeneic transfusion
Experimental group2:allogeneic transfusion
Experimental group3:autogeneic and allogeneic transfusion

Sponsors

Sanbo Brain Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: paitents undergoing raniotomyc and blood products transfusion.

Exclusion criteria

Exclusion criteria: 1.Hematological diease; 2.Liver dysfunction; 3.Anti-coagulation and/or anti-platelets treatment; 4.DVT and/or PE; 5.Abnormal coagulation function.

Design outcomes

Primary

MeasureTime frame
Blood cell count;Coagulation;—

Countries

China

Contacts

Public ContactXiong Jun

Sanbo Brain Hospital, Capital Medical University

xiongjun107@mail.ccmu.edu.cn+86 13810197854

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026